¿ø¹ß¼º ÁßÃ߽Űæ°è ¸²ÇÁÁ¾ÀÇ Ä¡·áÀü·«
Treatment Strategies for Primary Central Nervous System Lymphoma
±èÀϸ¸, ±è»óÈ£, ÇÔÈñÁ¤, À̵¿ÈÆ, ±èµ¿¿ø, ÀÓ¸¸ºó,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÀϸ¸ ( )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
±è»óÈ£ ( )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÇÔÈñÁ¤ ( )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
À̵¿ÈÆ ( )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
±èµ¿¿ø ( )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
ÀÓ¸¸ºó ( )
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
KMID : 0359820010300030334
Abstract
[ÃʷϾøÀ½:No abstract]
Å°¿öµå
Primary central nervous system lymphoma;Cranial irradiation;Chemothrapy;Methotrexate;Survival
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸